The global gene expression market size is calculated at USD 16.45 billion in 2025 and is forecasted to reach around USD 40.40 billion by 2034, accelerating at a CAGR of 10.50% from 2025 to 2034. The North America market size surpassed USD 6.99 billion in 2024 and is expanding at a CAGR of 10.51% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Gene Expression Industry Impact
5.2. COVID-19 - Impact Assessment for the Industry
5.3. COVID-19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Gene Expression Market Revenue and Volume Forecast, by Process
8.1.1. Sample collection
8.1.1.1. Market Revenue and Volume Forecast
8.1.2. Purification
8.1.2.1. Market Revenue and Volume Forecast
8.1.3. Data analysis and interpretation
8.1.3.1. Market Revenue and Volume Forecast
8.1.4. PCR analysis
8.1.4.1. Market Revenue and Volume Forecast
8.1.5. cDNA synthesis
8.1.5.1. Market Revenue and Volume Forecast
9.1. Gene Expression Market Revenue and Volume Forecast, by Product
9.1.1. Instruments
9.1.1.1. Market Revenue and Volume Forecast
9.1.2. Reagents and Consumables
9.1.2.1. Market Revenue and Volume Forecast
9.1.3. Services
9.1.3.1. Market Revenue and Volume Forecast
10.1. Gene Expression Market Revenue and Volume Forecast, by Capacity
10.1.1. Low- to Mid-Plex
10.1.1.1. Market Revenue and Volume Forecast
10.1.2. High-Plex
10.1.2.1. Market Revenue and Volume Forecast
11.1. Gene Expression Market Revenue and Volume Forecast, by End User
11.1.1. Pharmaceutical and biotechnology companies
11.1.1.1. Market Revenue and Volume Forecast
11.1.2. Diagnostic Laboratories
11.1.2.1. Market Revenue and Volume Forecast
11.1.3. Academic Research Centers
11.1.3.1. Market Revenue and Volume Forecast
12.1. North America
12.1.1. Market Revenue and Volume Forecast, by Process
12.1.2. Market Revenue and Volume Forecast, by Product
12.1.3. Market Revenue and Volume Forecast, by Capacity
12.1.4. Market Revenue and Volume Forecast, by End User
12.1.5. U.S.
12.1.5.1. Market Revenue and Volume Forecast, by Process
12.1.5.2. Market Revenue and Volume Forecast, by Product
12.1.5.3. Market Revenue and Volume Forecast, by Capacity
12.1.5.4. Market Revenue and Volume Forecast, by End User
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Volume Forecast, by Process
12.1.6.2. Market Revenue and Volume Forecast, by Product
12.1.6.3. Market Revenue and Volume Forecast, by Capacity
12.1.6.4. Market Revenue and Volume Forecast, by End User
12.2. Europe
12.2.1. Market Revenue and Volume Forecast, by Process
12.2.2. Market Revenue and Volume Forecast, by Product
12.2.3. Market Revenue and Volume Forecast, by Capacity
12.2.4. Market Revenue and Volume Forecast, by End User
12.2.5. UK
12.2.5.1. Market Revenue and Volume Forecast, by Process
12.2.5.2. Market Revenue and Volume Forecast, by Product
12.2.5.3. Market Revenue and Volume Forecast, by Capacity
12.2.5.4. Market Revenue and Volume Forecast, by End User
12.2.6. Germany
12.2.6.1. Market Revenue and Volume Forecast, by Process
12.2.6.2. Market Revenue and Volume Forecast, by Product
12.2.6.3. Market Revenue and Volume Forecast, by Capacity
12.2.6.4. Market Revenue and Volume Forecast, by End User
12.2.7. France
12.2.7.1. Market Revenue and Volume Forecast, by Process
12.2.7.2. Market Revenue and Volume Forecast, by Product
12.2.7.3. Market Revenue and Volume Forecast, by Capacity
12.2.7.4. Market Revenue and Volume Forecast, by End User
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Volume Forecast, by Process
12.2.8.2. Market Revenue and Volume Forecast, by Product
12.2.8.3. Market Revenue and Volume Forecast, by Capacity
12.2.8.4. Market Revenue and Volume Forecast, by End User
12.3. APAC
12.3.1. Market Revenue and Volume Forecast, by Process
12.3.2. Market Revenue and Volume Forecast, by Product
12.3.3. Market Revenue and Volume Forecast, by Capacity
12.3.4. Market Revenue and Volume Forecast, by End User
12.3.5. India
12.3.5.1. Market Revenue and Volume Forecast, by Process
12.3.5.2. Market Revenue and Volume Forecast, by Product
12.3.5.3. Market Revenue and Volume Forecast, by Capacity
12.3.5.4. Market Revenue and Volume Forecast, by End User
12.3.6. China
12.3.6.1. Market Revenue and Volume Forecast, by Process
12.3.6.2. Market Revenue and Volume Forecast, by Product
12.3.6.3. Market Revenue and Volume Forecast, by Capacity
12.3.6.4. Market Revenue and Volume Forecast, by End User
12.3.7. Japan
12.3.7.1. Market Revenue and Volume Forecast, by Process
12.3.7.2. Market Revenue and Volume Forecast, by Product
12.3.7.3. Market Revenue and Volume Forecast, by Capacity
12.3.7.4. Market Revenue and Volume Forecast, by End User
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Volume Forecast, by Process
12.3.8.2. Market Revenue and Volume Forecast, by Product
12.3.8.3. Market Revenue and Volume Forecast, by Capacity
12.3.8.4. Market Revenue and Volume Forecast, by End User
12.4. MEA
12.4.1. Market Revenue and Volume Forecast, by Process
12.4.2. Market Revenue and Volume Forecast, by Product
12.4.3. Market Revenue and Volume Forecast, by Capacity
12.4.4. Market Revenue and Volume Forecast, by End User
12.4.5. GCC
12.4.5.1. Market Revenue and Volume Forecast, by Process
12.4.5.2. Market Revenue and Volume Forecast, by Product
12.4.5.3. Market Revenue and Volume Forecast, by Capacity
12.4.5.4. Market Revenue and Volume Forecast, by End User
12.4.6. North Africa
12.4.6.1. Market Revenue and Volume Forecast, by Process
12.4.6.2. Market Revenue and Volume Forecast, by Product
12.4.6.3. Market Revenue and Volume Forecast, by Capacity
12.4.6.4. Market Revenue and Volume Forecast, by End User
12.4.7. South Africa
12.4.7.1. Market Revenue and Volume Forecast, by Process
12.4.7.2. Market Revenue and Volume Forecast, by Product
12.4.7.3. Market Revenue and Volume Forecast, by Capacity
12.4.7.4. Market Revenue and Volume Forecast, by End User
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Volume Forecast, by Process
12.4.8.2. Market Revenue and Volume Forecast, by Product
12.4.8.3. Market Revenue and Volume Forecast, by Capacity
12.4.8.4. Market Revenue and Volume Forecast, by End User
12.5. Latin America
12.5.1. Market Revenue and Volume Forecast, by Process
12.5.2. Market Revenue and Volume Forecast, by Product
12.5.3. Market Revenue and Volume Forecast, by Capacity
12.5.4. Market Revenue and Volume Forecast, by End User
12.5.5. Brazil
12.5.5.1. Market Revenue and Volume Forecast, by Process
12.5.5.2. Market Revenue and Volume Forecast, by Product
12.5.5.3. Market Revenue and Volume Forecast, by Capacity
12.5.5.4. Market Revenue and Volume Forecast, by End User
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Volume Forecast, by Process
12.5.6.2. Market Revenue and Volume Forecast, by Product
12.5.6.3. Market Revenue and Volume Forecast, by Capacity
12.5.6.4. Market Revenue and Volume Forecast, by End User
13.1. QIAGEN
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Quest Diagnostics, Inc.
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. F. Hoffmann-La Roche Ltd.
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Illumina, Inc.
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. PerkinElmer, Inc.
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Bio-Rad Laboratories
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Thermo Fisher Scientific, Inc.
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Agilent Technologies
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. GE Healthcare
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Promega Corp.
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
15.1. About Us
15.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample